Erudio Healtherudio.com
Drug
Pegylated liposomal doxorubicin trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying pegylated liposomal doxorubicin: KEYNOTE-B49. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 8 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| KEYNOTE-B49 NCT04895358 · Merck Sharp & Dohme LLC | HR+/HER2- locally recurrent inoperable or metastatic breast cancer | Phase 3 | 150 | 58 | Focused | Nov 13, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| MIRASOL NCT04209855 · AbbVie DeepView → | platinum-resistant ovarian cancer with high FRα expression | Phase 3 | Deep | View | |||
| AURELIA NCT00976911 · Hoffmann-La Roche DeepView → | platinum-resistant recurrent ovarian cancer | Phase 3 | Deep | View | |||
| RAMP 301 NCT06072781 · Verastem, Inc. DeepView → | recurrent low-grade serous ovarian cancer | Phase 3 | Deep | View | |||
| TroFuse-010 NCT06312176 · Merck Sharp & Dohme LLC StandardView → | HR+/HER2- unresectable locally advanced or metastatic breast cancer | Phase 3 | Standard | View | |||
| FORWARD I NCT02631876 · ImmunoGen, Inc. FocusedView → | folate receptor alpha-positive platinum-resistant epithelial ovarian cancer | Phase 3 | Focused | View | |||
| FRAmework-01 NCT07213804 · Eli Lilly and Company FocusedView → | platinum-resistant and platinum-sensitive ovarian cancer | Phase 3 | Focused | View | |||
| HERTHENA-Breast04 NCT07060807 · Merck Sharp & Dohme LLC FocusedView → | Not given | Phase 3 | Focused | View | |||
| NCT03618550 NCT03618550 · Memorial Sloan Kettering Cancer Center FocusedView → | relapsed or refractory classical Hodgkin lymphoma | Phase 2 | Focused | View | |||